This announcement is a separate document:
山东步长制药股份有限公司拟对收购通化谷红制药有限公司股权形成的商誉进行减值测试涉及的资产组可收回金额资产评估报告
Shandong Buchang Pharmaceutical Co., Ltd. plans to conduct an impairment test on the goodwill formed from the acquisition of shares in Tonghua Guhong Pharmaceutical Co., Ltd. Asset Group Recoverable Amount Asset Assessment Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated